The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients’ Lipid Profiles
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00316641
Verified March 2006 by China Medical University Hospital. Recruitment status was: Recruiting
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
20 Years to 65 Years (Adult)
Sexes Eligible for Study:
Patient aged 20-65 years;either sex
Patient diagnosed with hyperlipidemia(fasting levels of TC>=200mg/dL),or TG>=200mg/dL but <400mg/dL,or LDL-C>=130mg/dL)
Patient who has signed the informed consent form
Patient with pregnancy (or child bearing potential),or in lactation
Patient with any lipid regulating agents within 4 weeks prior to study period
Patient currently taking concomitant medications, such as oral contraceptives, or any medical treatment capable of interfering with lipid metabolism(eg thiazides, β-blockers, cyclosporins, itraconazole erythromycin,and danazol)
Patient with medical history of hypothyroidism, pancreatitis, cholestasis, nephrotic syndrome, gall bladder disease, primary biliary cirrhosis.
Patient with liver dysfunction (SGOT or SGPT>2x ULN)
Patient with renal insufficiency (serum creatinine>1.3mg/dL)
Patient with myocardial infarction,cerebrovascular disease,or major operations within 6 months prior to the study period.